AzTrials
AzTrials

Bulimia NervosaSRBNNCT02997475

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

An observational study of Bulimia Nervosa, run by University of California, San Diego at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate areas of the brain responsible for self-regulation in adult women who have never had an eating disorder with women who have bulimia nervosa. Read more about this study

Who is it for?
Ages 18 to 35 years, women onlyHealthy volunteers can take part
Conditions the study is for
Bulimia Nervosa
How many people
89 participants
Where
1 siteUnited States
Study dates
Jun 2016to 31 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Women (ages 18-35 years) with bulimia nervosa, and age- and BMI-matched healthy controls.

General Inclusion Criteria:

  • Female
  • Right-handed
  • Between the ages of 18 and 35 years *For Women with Bulimia Nervosa:
  • Binge eating (i.e., eating a large amount of food while experiencing a sense of loss of control)
  • Purging via self-induced vomiting (other methods may also be endorsed)

General Exclusion Criteria:

  • Current significant medical illness or condition (e.g., diabetes, thyroid disease)
  • Pregnancy, planned pregnancy, or lactation during the study period
  • Non-removable metallic objects in the body

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCSD Eating Disorders Center for Treatment and Research

    San Diego, California, 92121

Other trials in United States

About this study

The purpose of this study is to investigate areas of the brain responsible for self-regulation in adult women who have never had an eating disorder with women who have bulimia nervosa. More specifically, investigators are interested in changes in brain activation (e.g., changes in blood flow and oxygen use) when inhibiting responses and regulating emotions. Data collection will rely on a technology called functional magnetic resonance imaging (fMRI).

Conditions
Bulimia Nervosa
Keywords
Bulimia Nervosa, Bulimia, fMRI, Emotion Regulation, Response Inhibition
Medical subject headings
Bulimia Nervosa, Bulimia, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02997475
Study groupRoleWhat they receive
Women with Bulimia NervosaNot described
Women Healthy ControlsNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-Regulatory Control

    Functional Magnetic Resonance Imaging will be used to assess brain activation associated with motor inhibitory control and affect regulation in women with bulimia nervosa (BN)

    Measured: Day 2 (fMRI Scan)

Secondary outcomes (2)
  1. Goal-Directed Action Control

    An computerized instrumental learning task will be used to assess performance of women with and without bulimia nervosa.

    Measured: Day 1

  2. Eating Disorder Relevance

    The Eating Disorder Examination (EDE) will be conducted to assess relative associations of motor, affective, and goal-directed action control with bulimia nervosa severity.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2016 (estimated)
  2. Study startJun 2016
  3. Primary completion31 Jul 2022
  4. Study completion31 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02997475
Sponsor's protocol ID
151514
Other IDs
F32MH108311
Acronym
SRBN
Status last verified
Jan 2023
First submitted
25 Oct 2016
Last updated
17 Jan 2023
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bulimia Nervosa, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-Regulatory Control (time frame: Day 2 (fMRI Scan)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in